Home » Newsletters » BioWorld Science

BioWorld Science

Aug. 31, 2015

View Archived Issues

Takeda synthesizes tetrahydronaphthalene Raf inhibitors with selectivity over hERG

University of Utah patents re-engineered tumor suppressor p53

Fixed Phage reports bacteriophage-based antibacterials

LMG-324 begins first-in-human study for AMD

Novel FFAR4 agonist shows glucose-lowering effect in vivo

Work at Merck & Co. leads to identification of mineralcorticoid receptor antagonists

Challenge award supports NantKwest's natural killer cell-based therapy for prostate cancer

Celgene completes acquisition of Receptos

Onconova Therapeutics files European CTAs for global phase III trial of rigosertib

Purdue Pharma discloses Nav1.7 channel blockers

Lilly patents GPR142 agonists

Incyte divulges LSD1 inhibitors

Celyad and Medisun sign license agreement for C-Cure in Greater China

Merck & Co. introduces cathepsin K inhibitors

Bayer and DKFZ present inhibitors of mutated IDH1

BMS and QIMR Berghofer Medical Research Institute partner in immuno-oncology

Cryogel injectable biomaterial provides novel cancer vaccine platform

FDA grants priority review to Telesta's BLA for MCNA

FDA approves Aptiom as monotherapy for partial-onset seizures

Yervoy Injection launched in Japan

Novartis launches Farydak capsules for multiple myeloma in Japan

Nintedanib launched in Japan for the treatment of idiopathic pulmonary fibrosis

Three-protein panel can detect pancreatic cancer from urine samples

Gilead launches Harvoni in Japan for the treatment of genotype 1 chronic HCV infection

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Dec. 24, 2024.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for December 24, 2024.
Enhanced Cognition: Lewy body dementia phase II pumps stock
BioWorld
Investors will get more details during the International Lewy Body Dementia Conference in Amsterdam late next month, but Wall Street is already buzzing about...
Experimental mRNA gene therapy suppresses preeclampsia in mice
BioWorld MedTech
A gene therapy based on an enhanced lipid nanoparticle (LNP) loaded with vascular endothelial growth factor (VEGF) mRNA could be developed for the treatment of...
Probing bidirectional cancer-autoimmune link can yield new targets
BioWorld Science
Cancer and autoimmunity are “often thought of as being at opposite ends of the immune response,” Ana Anderson told her audience at a joint meeting of the NIH’s...

BioWorld Premium

Enjoy extended coverage for the most complete market view with BioWorld, BioWorld MedTech, and BioWorld Asia in a single, easy to access subscription.